{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:48:28Z","timestamp":1753890508216,"version":"3.41.2"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Therapies that modulate and appropriately direct the immune response are promising candidates for the treatment of infectious diseases. One such candidate therapeutic is DZ13, a short, synthetic, single-stranded DNA molecule. This molecule has enzymatic activity and can modulate the immune response by binding to and degrading the mRNA encoding a key immuno-regulatory molecule. Originally developed and entering clinical trials as an anti-cancer agent, DZ13 has also been evaluated as a treatment for viral infections, and has been shown to provide protection against infection with influenza virus in a mouse model of infection. In this work, we evaluated whether the immuno-modulatory properties of DZ13 could provide protection against the potential biothreat pathogen <jats:italic>Burkholderia pseudomallei<\/jats:italic> which causes the neglected tropical disease melioidosis. Treatment of mice infected with <jats:italic>B. pseudomallei<\/jats:italic> demonstrated that DZ13 did indeed provide excellent protection after only two post-exposure treatments. However, our data indicated that the enzymatic activity contained in DZ13 was not required for protection, with control oligonucleotide treatments lacking activity against the target mRNA equally as protective against <jats:italic>B. pseudomallei<\/jats:italic>. We have designed new sequences to study the mechanism of protection further. These novel sequences offer enhanced protection against infection, but are not directly anti-microbial and do not appear to be stimulating the immune system via TLR9 or other key innate immune sensors, despite containing CpG motifs. The molecular mechanism of these novel sequences remains to be elucidated, but the data highlights that these oligonucleotide-sensing pathways are attractive and relevant targets to modulate during bacterial and viral infections.<\/jats:p>","DOI":"10.3389\/fcimb.2024.1458435","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T05:10:23Z","timestamp":1729228223000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-stranded DNA oligonucleotides containing CpG motifs are non-stimulatory in vitro but offer protection in vivo against Burkholderia pseudomallei"],"prefix":"10.3389","volume":"14","author":[{"given":"Andrew","family":"Scott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joann","family":"Prior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad","family":"Stratilo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonie","family":"Unterholzner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"D\u2019Elia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002212","article-title":"Post-exposure therapeutic efficacy of COX-2 inhibition against Burkholderia pseudomallei","volume":"7","author":"Asakrah","year":"2013","journal-title":"PloS Negl. Trop. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"139ra82","DOI":"10.1126\/scitranslmed.3003960","article-title":"DNAzyme targeting c-jun suppresses skin cancer growth","volume":"4","author":"Cai","year":"2012","journal-title":"Sci. Trans. Med."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002452","article-title":"Inflammasome-dependent pyroptosis and IL-18 protect against Burkholderia pseudomallei lung infection while IL-1\u03b2 is deleterious","volume":"7","author":"Ceballos-Olvera","year":"2011","journal-title":"PloS Pathog."},{"key":"B4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ijid.2014.07.025","article-title":"High HMGB1 level is associated with poor outcome of septicemic melioidosis","volume":"28","author":"Charoensup","year":"2014","journal-title":"Int. J. Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1128\/cmr.18.2.383-416.2005","article-title":"Melioidosis: epidemiology, pathophysiology, and management","volume":"18","author":"Cheng","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1086\/519261","article-title":"A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand","volume":"45","author":"Cheng","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.1128\/AAC.01301-08","article-title":"Dosing regimens of cotrimoxazole (trimethoprim-sulfamethoxazole) for melioidosis","volume":"53","author":"Cheng","year":"2009","journal-title":"Antimicrobial. Agents Chemother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/S0140-6736(12)62166-7","article-title":"Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER)","volume":"381","author":"Cho","year":"2013","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.1055\/s-0034-1398389","article-title":"Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment","volume-title":"Seminars in respiratory and critical care medicine","author":"Currie","year":"2015"},{"key":"B10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1089\/oli.2009.0219","article-title":"Sequence-related off-target effect of Dz13 against human tumor cells and safety in adult and fetal mice following systemic administration","volume":"20","author":"Dass","year":"2010","journal-title":"Oligonucleotides"},{"key":"B11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1089\/oli.2009.0226","article-title":"Dz13, a c-jun DNAzyme, is a potent inducer of caspase-2 activation","volume":"20","author":"Dass","year":"2010","journal-title":"Oligonucleotides"},{"key":"B12","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-818480-6.00007-2","article-title":"Combating biothreat pathogens: ongoing efforts for countermeasure development and unique challenges","volume-title":"Drug Discovery Targeting Drug-Resistant Bacteria","author":"Duplantier","year":"2020"},{"key":"B13","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1093\/infdis\/jir301","article-title":"Combining vaccination and postexposure CpG therapy provides optimal protection against lethal sepsis in a biodefense model of human melioidosis","volume":"204","author":"Easton","year":"2011","journal-title":"J. Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/j.1747-0285.2011.01166.x","article-title":"Dz13: c-jun downregulation and tumour cell death","volume":"78","author":"Elahy","year":"2011","journal-title":"Chem. Biol. Drug Design"},{"key":"B15","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/nbt1225","article-title":"Suppression of vascular permeability and inflammation by targeting of the transcription factor c-Jun","volume":"24","author":"Fahmy","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1128\/JCM.41.5.2068-2079.2003","article-title":"Multilocus Sequence Typing and Evolutionary Relationships among the Causative Agents of Melioidosis and Glanders, Burkholderia pseudomallei and Burkholderia mallei","volume":"41","author":"Godoy","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1089\/oli.2008.0139","article-title":"Dz13, a DNAzyme targeting c-jun, induces off-target cytotoxicity in endothelial cells with features of nonapoptotic programmed cell death","volume":"18","author":"Gozar","year":"2008","journal-title":"Oligonucleotides"},{"key":"B18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1152\/ajplegacy.1947.150.1.70","article-title":"Measurement of the respiratory volumes of laboratory animals","volume":"150","author":"Guyton","year":"1947","journal-title":"Am. J. Physiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1017\/S0022172400015801","article-title":"The respiratory retention of bacterial aerosols: experiments with radioactive spores","volume":"51","author":"Harper","year":"1953","journal-title":"Epidemiol. Infect."},{"key":"B20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.vascn.2003.07.001","article-title":"The automated bioaerosol exposure system: preclinical platform development and a respiratory dosimetry application with nonhuman primates","volume":"49","author":"Hartings","year":"2004","journal-title":"J. Pharmacol. Toxicological Methods"},{"key":"B21","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"14240","DOI":"10.1073\/pnas.0403302101","article-title":"Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei","volume":"101","author":"Holden","year":"2004","journal-title":"Proc. Natl. Acad. Sci. United States America"},{"article-title":"Photon, proton, and neutron interaction data for body tissues","volume-title":"ICRU Report 46","year":"1992","key":"B23"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034176","article-title":"Prophylactic application of CpG oligonucleotides augments the early host response and confers protection in acute melioidosis","volume":"7","author":"Judy","year":"2012","journal-title":"PloS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e389","DOI":"10.1111\/tbed.2016.63.issue-5","article-title":"Retrospective study on fatal melioidosis in captive zoo animals in Thailand","volume":"63","author":"Kasantikul","year":"2016","journal-title":"Transboundary Emerging Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd.2017.162","article-title":"Host-directed therapies for bacterial and viral infections","volume":"17","author":"Kaufmann","year":"2018","journal-title":"Nat. Rev. Drug Discovery"},{"key":"B27","doi-asserted-by":"publisher","first-page":"22985","DOI":"10.1074\/jbc.M200977200","article-title":"c-Jun regulates vascular smooth muscle cell growth and neointima formation after arterial injury: inhibition by a novel DNA enzyme targeting c-Jun","volume":"277","author":"Khachigian","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"12631","DOI":"10.1073\/pnas.95.21.12631","article-title":"Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs","volume":"95","author":"Krieg","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijid.2015.09.003","article-title":"Immune profiling of the progression of a BALB\/c mouse aerosol infection by Burkholderia pseudomallei and the therapeutic implications of targeting HMGB1","volume":"40","author":"Laws","year":"2015","journal-title":"Int. J. Infect. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1080\/14787210.2018.1496330","article-title":"The treatment of melioidosis: is there a role for repurposed drugs? A proposal and review","volume":"17","author":"Laws","year":"2019","journal-title":"Expert Rev. anti-infective Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1089\/104454903770238094","article-title":"Structural characterization of the inhibitory DNA motif for the type A (D)-CpG\u2013induced cytokine secretion and NK-cell lytic activity in mouse spleen cells","volume":"22","author":"Lenert","year":"2003","journal-title":"DNA Cell Biol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002105","article-title":"Systematic review and consensus guidelines for environmental sampling of Burkholderia pseudomallei","volume":"7","author":"Limmathurotsakul","year":"2013","journal-title":"PloS Negl. Trop. Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"15008","DOI":"10.1038\/nmicrobiol.2015.8","article-title":"Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis","volume":"1","author":"Limmathurotsakul","year":"2016","journal-title":"Nat. Microbiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1128\/IAI.70.2.504-511.2002","article-title":"Model of differential susceptibility to mucosal Burkholderia pseudomallei infection","volume":"70","author":"Liu","year":"2002","journal-title":"Infect. Immun."},{"key":"B35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0021-8502(73)90006-2","article-title":"The Collison nebulizer: description, performance and application","volume":"4","author":"May","year":"1973","journal-title":"J.\u00a0Aerosol Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1136\/oem.14.4.287","article-title":"The efficiency of various liquid impinger samplers in bacterial aerosols","volume":"14","author":"May","year":"1957","journal-title":"Br. J. Ind. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s13238-011-1113-3","article-title":"c-Jun, at the crossroad of the signaling network","volume":"2","author":"Meng","year":"2011","journal-title":"Protein Cell"},{"key":"B38","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41579-023-00972-5","article-title":"Burkholderia pseudomallei and melioidosis","volume":"22","author":"Meumann","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3390\/antibiotics12030506","article-title":"The BALB\/c mouse model for the evaluation of therapies to treat infections with aerosolized Burkholderia pseudomallei","volume":"12","author":"Nelson","year":"2023","journal-title":"Antibiotics"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003586","article-title":"Intravenous therapy duration and outcomes in melioidosis: a new treatment paradigm","volume":"9","author":"Pitman","year":"2015","journal-title":"PloS Negl. Trop. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"5983","DOI":"10.1016\/j.vaccine.2014.08.035","article-title":"Comparison of the protective effects of killed Burkholderia pseudomallei and CpG oligodeoxynucleotide against live challenge","volume":"32","author":"Puangpetch","year":"2014","journal-title":"Vaccine"},{"key":"B42","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1128\/CVI.05545-11","article-title":"Cationic liposomes extend the immunostimulatory effect of CpG oligodeoxynucleotide against Burkholderia pseudomallei infection in BALB\/c mice","volume":"19","author":"Puangpetch","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1476-8518-8-2","article-title":"CpG oligodeoxyribonucleotides protect mice from Burkholderia pseudomallei but not Francisella tularensis Schu S4 aerosols","volume":"8","author":"Rozak","year":"2010","journal-title":"J. Immune Based Therapies Vaccines"},{"key":"B44","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1086\/jid.2000.181.issue-2","article-title":"Prognostic value of cytokine concentrations (tumor necrosis factor-\u03b1, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis","volume":"181","author":"Simpson","year":"2000","journal-title":"J. Infect. Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1439-0450.2004.00797.x","article-title":"Melioidosis in animals: a review on epizootiology, diagnosis and clinical presentation","volume":"51","author":"Sprague","year":"2004","journal-title":"J. Veterinary Med. Ser. B"},{"key":"B46","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1099\/jmm.0.47596-0","article-title":"Burkholderia pseudomallei aerosol infection results in differential inflammatory responses in BALB\/c and C57Bl\/6 mice","volume":"57","author":"Tan","year":"2008","journal-title":"J. Med. Microbiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/jac\/dkh471","article-title":"Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents","volume":"54","author":"Thibault","year":"2004","journal-title":"J. Antimicrobial. Chemother."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2012.00101","article-title":"Particle-size dependent effects in the Balb\/c murine model of inhalational melioidosis","volume":"2","author":"Thomas","year":"2012","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"100058","DOI":"10.1016\/j.crphar.2021.100058","article-title":"Host directed therapies: COVID-19 and beyond","volume":"2","author":"Tripathi","year":"2021","journal-title":"Curr. Res. Pharmacol. Drug Discovery"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1128\/IAI.74.3.1944-1948.2006","article-title":"A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei","volume":"74","author":"Waag","year":"2006","journal-title":"Infect. Immun."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1128\/mra.01529-18","article-title":"Genome resequencing of laboratory stocks of Burkholderia pseudomallei K96243","volume":"8","author":"Wagley","year":"2019","journal-title":"Microbiol. Resource Announcements"},{"key":"B52","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/SHK.0000000000000625","article-title":"Therapeutic administration of a monoclonal anti-IL-1\u03b2 antibody protects against experimental melioidosis","volume":"46","author":"Weehuizen","year":"2016","journal-title":"Shock"},{"key":"B53","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0140-6736(89)90768-X","article-title":"Halving of mortality of severe melioidosis by ceftazidime","volume":"334","author":"White","year":"1989","journal-title":"Lancet"},{"key":"B54","doi-asserted-by":"publisher","first-page":"17107","DOI":"10.1038\/nrdp.2017.107","article-title":"Melioidosis","volume":"4","author":"Wiersinga","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B55","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1128\/IAI.00080-07","article-title":"Endogenous interleukin-18 improves the early antimicrobial host response in severe melioidosis","volume":"75","author":"Wiersinga","year":"2007","journal-title":"Infect. Immun."},{"key":"B56","doi-asserted-by":"publisher","first-page":"4494","DOI":"10.1128\/IAI.72.8.4494-4502.2004","article-title":"Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei","volume":"72","author":"Wongratanacheewin","year":"2004","journal-title":"Infect. Immun."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/j.bbadis.2014.04.017","article-title":"Regulatory roles of c-jun in H5N1 influenza virus replication and host inflammation","volume":"1842","author":"Xie","year":"2014","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.micpath.2016.12.024","article-title":"DNAzymes Dz13 target the c-jun possess antiviral activity against influenza A viruses","volume":"103","author":"Zhang","year":"2017","journal-title":"Microbial Pathogenesis"},{"key":"B59","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1089\/oli.1.2000.10.381","article-title":"Requirements for effective inhibition of immunostimulatory CpG motifs by neutralizing motifs","volume":"10","author":"Zhao","year":"2000","journal-title":"Antisense Nucleic Acid Drug Dev."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1458435\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T05:10:26Z","timestamp":1729228226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1458435\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":59,"alternative-id":["10.3389\/fcimb.2024.1458435"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2024.1458435","relation":{},"ISSN":["2235-2988"],"issn-type":[{"type":"electronic","value":"2235-2988"}],"subject":[],"published":{"date-parts":[[2024,10,18]]},"article-number":"1458435"}}